13D/13G Filings - Lipocine Inc. (LPCN)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-10
08:22 am
Purchase
2021-12-3113GLipocine Inc.
LPCN
The Vanguard Group224,116
4.320%
12,880increase
(+6.10%)
Filing
History
2021-02-10
7:00 pm
Sale
2020-12-3113GLipocine Inc.
LPCN
RENAISSANCE TECHNOLOGIES LLC0
0.000%
-111,839decrease
(Position Closed)
Filing
History
2021-02-10
2:41 pm
Sale
2020-12-3113GLipocine Inc.
LPCN
Hudson Bay Capital Management LP0
0.000%
-231,329decrease
(Position Closed)
Filing
History
2021-02-10
11:14 am
Purchase
2020-12-3113GLipocine Inc.
LPCN
The Vanguard Group211,236
5.470%
211,236increase
(New Position)
Filing
History
2021-01-05
09:20 am
Sale
2020-12-3113GLipocine Inc.
LPCN
SABBY MANAGEMENT LLC0
0.000%
-197,726decrease
(Position Closed)
Filing
History
2020-02-25
12:39 pm
Purchase
2020-02-2513GLipocine Inc.
LPCN
SABBY MANAGEMENT LLC197,726
11.000%
93,588increase
(+89.87%)
Filing
History
2020-02-12
2:27 pm
Purchase
2019-12-1913GLipocine Inc.
LPCN
RENAISSANCE TECHNOLOGIES LLC111,839
5.360%
111,839increase
(New Position)
Filing
History